Search research articles
Contact Us
Filters
Showing results (91-100 of 178) with videos related to
Page
of 18
Sort By:
Scientific Reports
|
June 22, 2016
Negative autoregulation of BMP dependent transcription by SIN3B splicing reveals a role for RBM39
Noel Faherty, Matthew Benson, Eshita Sharma, et al.
American Journal of Surgery
|
February 17, 2021
Impact of policy-based and institutional interventions on postoperative opioid prescribing practices
Ashley Titan, Alexis Doyle, Kayla Pfaff, et al.
JMIR Formative Research
|
October 2, 2020
Mental Health During the COVID-19 Pandemic in the United States: Online Survey
Jennifer S Jewell, Charlotte V Farewell, Courtney Welton-Mitchell, et al.
Antimicrobial Agents and Chemotherapy
|
March 26, 2003
MexXY-OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides
Didier Hocquet, Christelle Vogne, Farid El Garch, et al.
Seminars in Oncology
|
April 2, 2023
Outcomes with panobinostat in heavily pretreated multiple myeloma patients
Darren Pan, Tarek H Mouhieddine, Ranjan Upadhyay, et al.
Muscle & Nerve
|
September 18, 2022
Diagnostic criteria in amyotrophic lateral sclerosis: Time for a change
Gordon Jewett, Shahin Khayambashi, Geoffrey S Frost, et al.
Journal of Addictions Nursing
|
June 9, 2016
Implementation of Recovery Programming on an Inpatient Acute Psychiatric Unit and Its Impact on Readmission
Renee D Koval, James Mcdonagh, Anouk Grubaugh, et al.
Muscle & Nerve
|
June 8, 2022
Gold Coast criteria expand clinical trial eligibility in amyotrophic lateral sclerosis
Gordon Jewett, Shahin Khayambashi, Geoffrey S Frost, et al.
The Clinical Neuropsychologist
|
December 15, 2004
The clinical diagnosis of vascular dementia: A comparison among four classification systems and a proposal for a new paradigm
Stephanie A Cosentino, Angela Lee Jefferson, Marissa Carey, et al.
Journal of Clinical Pharmacology
|
October 24, 2013
Pharmacokinetics of dalfampridine extended release 7.5-mg tablets in healthy subjects and individuals with mild and moderate renal impairment: an open-label study
Emil Samara, Peter Winkle, Patricia Pardo, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 178) with videos related to
Sort By:
Page
of 18
Scientific Reports
|
June 22, 2016
Negative autoregulation of BMP dependent transcription by SIN3B splicing reveals a role for RBM39
Noel Faherty, Matthew Benson, Eshita Sharma, et al.
American Journal of Surgery
|
February 17, 2021
Impact of policy-based and institutional interventions on postoperative opioid prescribing practices
Ashley Titan, Alexis Doyle, Kayla Pfaff, et al.
JMIR Formative Research
|
October 2, 2020
Mental Health During the COVID-19 Pandemic in the United States: Online Survey
Jennifer S Jewell, Charlotte V Farewell, Courtney Welton-Mitchell, et al.
Antimicrobial Agents and Chemotherapy
|
March 26, 2003
MexXY-OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides
Didier Hocquet, Christelle Vogne, Farid El Garch, et al.
Seminars in Oncology
|
April 2, 2023
Outcomes with panobinostat in heavily pretreated multiple myeloma patients
Darren Pan, Tarek H Mouhieddine, Ranjan Upadhyay, et al.
Muscle & Nerve
|
September 18, 2022
Diagnostic criteria in amyotrophic lateral sclerosis: Time for a change
Gordon Jewett, Shahin Khayambashi, Geoffrey S Frost, et al.
Journal of Addictions Nursing
|
June 9, 2016
Implementation of Recovery Programming on an Inpatient Acute Psychiatric Unit and Its Impact on Readmission
Renee D Koval, James Mcdonagh, Anouk Grubaugh, et al.
Muscle & Nerve
|
June 8, 2022
Gold Coast criteria expand clinical trial eligibility in amyotrophic lateral sclerosis
Gordon Jewett, Shahin Khayambashi, Geoffrey S Frost, et al.
The Clinical Neuropsychologist
|
December 15, 2004
The clinical diagnosis of vascular dementia: A comparison among four classification systems and a proposal for a new paradigm
Stephanie A Cosentino, Angela Lee Jefferson, Marissa Carey, et al.
Journal of Clinical Pharmacology
|
October 24, 2013
Pharmacokinetics of dalfampridine extended release 7.5-mg tablets in healthy subjects and individuals with mild and moderate renal impairment: an open-label study
Emil Samara, Peter Winkle, Patricia Pardo, et al.
Page
of 18